Study Stopped
Not activated at the site level
Ultrasonic Treatment of Food Addiction
USFADD
Noninvasive Targeted Neuromodulation for Treatment of Food Addiction
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study will evaluate a new form of non-invasive deep brain therapy for food addiction. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled trial. The trial will evaluate brain target engagement using magnetic resonance imaging, Food Cravings Questionnaire-State, and changes in subject's weight over the course of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedStudy Start
First participant enrolled
March 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2024
CompletedMay 22, 2025
April 1, 2025
Same day
January 31, 2024
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in body weight (%) from baseline week 0 to week 16
The body weight will be quantified with respect to baseline (100%), taken prior to the first intervention.
The body weight will be taken prior to each intervention (once per week)
Number of participants who achieved body weight reduction >= 5%
Proportion of subjects who have lost at least 5% of their weight at week 16 relative to the baseline week 0.
Assessment at week 16
Food Cravings Questionnaire-State
This 15-item questionnaire measures immediate level of food craving, each item ranging from 1 (strongly disagree) to 5 (strongly agree). Higher total scores indicate stronger desire to eat.
During and immediately after each weekly intervention
Hamilton Depression Rating Scale, 17 item
This 17-item questionnaire measures the severity of depression. Scores range between 0 (least severe) to 52 (most severe).
For up to 16 weeks
Study Arms (2)
Active stimulation
ACTIVE COMPARATORLow-intensity transcranial focused ultrasound stimulation of deep brain targets involved in food addiction
Sham stimulation
SHAM COMPARATORZero-intensity transcranial focused ultrasound stimulation of deep brain targets involved in food addiction
Interventions
Diadem ultrasonic transducer array delivers focused low-intensity ultrasound stimulation
Diadem ultrasonic transducer array delivers focused zero-intensity ultrasound stimulation
Eligibility Criteria
You may qualify if:
- History of at least one self-reported unsuccessful dietary effort to lose body weight
- Body mass index more than or equal to 30 kg/m\^2 or more than or equal to 25 kg/m\^2 with the presence of at least one of the following weight-related comorbidities: hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease.
You may not qualify if:
- Lifetime history of a serious suicide attempt
- MRI intolerance or contraindication
- Pregnant or breast feeding
- Diabetic (HbA1c more than 48 mmol/mol or 6.5%)
- A self-reported change in body weight more than 10 lbs within 60 days before screening
- Clinically inappropriate for participation in the study as determined by the study team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah
Salt Lake City, Utah, 84103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Kubanek, PhD
University of Utah
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 8, 2024
Study Start
March 3, 2024
Primary Completion
March 3, 2024
Study Completion
March 3, 2024
Last Updated
May 22, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share